Results 161 to 170 of about 1,375,308 (279)

Visceral adiposity and insulin resistance in polycystic ovarian syndrome - A cross-sectional, observational study. [PDF]

Eur J Obstet Gynecol Reprod Biol X
Sridharan A, Guddeti A, Vasamsetti SR, Kumar S, Aleem S, Mashetty S, Alekya LA, Hari Kumar K.   +7 more
europepmc   +1 more source

OJOG Defining prediabetes in polycystic ovarian syndrome

, 2011
Objective: The article will review the associations between Prediabetes (PD) and Polycystic Ovarian Syndrome (PCOS) and present factors that decrease the progression of PD into type 2 diabetes mellitus (T2DM).Metformin will also be examined for its role ...
Mark P. Trolice
core  

Use of Glucagon‐Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009–2024

Acta Psychiatrica Scandinavica, Volume 154, Issue 4, Page 305-312, October 2026.
ABSTRACT Introduction Diabetes, obesity and bipolar disorder often co‐occur and may have shared pathophysiology. Glucagon‐like peptide 1 receptor agonists (GLP‐1RA) treat diabetes and obesity but their impact on bipolar disorder is unknown. In this era of stagnated pharmacotherapy, we examined psychiatric hospitalisation and absence from work due to ...
Heidi Taipale, Mark Taylor, Markku Lähteenvuo, Ellenor Mittendorfer‐Rutz, Antti Tanskanen, Jari Tiihonen   +5 more
wiley   +1 more source

Placental dysfunction reflects endocrine impairment and trophoblast alterations in polycystic ovarian syndrome. [PDF]

Sci Rep
Mahapatra A, Pillai G, Rana R, Shah Z, Nampoothiri L.   +4 more
europepmc   +1 more source

Trends in Anti‐Müllerian Hormone (AMH) Testing for Fertility Assessment in Australian General Practice, 2011–2021: A Retrospective Open Cohort Study

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 5, October 2026.
ABSTRACT Background Anti‐Müllerian hormone (AMH) tests are often promoted as a measure of fertility; however, AMH adds limited predictive value beyond age alone for estimating the likelihood of live birth in couples trying to conceive. Aims This study aimed to examine longitudinal trends in the rate of AMH testing for fertility in the Australian ...
Gizat M. Kassie, Tessa Copp, Sarah Lensen, Danielle Mazza, Jacqueline A. Boyle, Luke E. Grzeskowiak   +5 more
wiley   +1 more source

Signal Detection and Pharmacovigilance Analysis of Tamoxifen, Clomiphene, and Letrozole in Polycystic Ovarian Syndrome: A FAERS Database Study. [PDF]

Int J Womens Health
Zhang D, Zhou J.
europepmc   +1 more source

Externally validated risk prediction models for gestational diabetes mellitus: A systematic review and meta‐analysis

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 1918-1931, October 2026.
A systematic review of 33 gestational diabetes risk prediction models found fair discrimination but significant methodological weaknesses. With 69% of studies at high risk of bias, future research must adopt rigorous, scalable validation strategies to enhance clinical utility.
Beminate Lemma Seifu, Yitayeh Belsti, Nigus Bililign Yimer, Rebecca F. Goldstein, Joanne Enticott, Helena Teede   +5 more
wiley   +1 more source

Reduced CAG Repeats in the Androgen Receptor Gene May Independently Cause Polycystic Ovarian Syndrome. [PDF]

Curr Issues Mol Biol
Sharma R, Shain DH.
europepmc   +1 more source

Early‐ vs. late‐onset gestational diabetes: Differential impact on maternal and neonatal outcomes

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2012-2022, October 2026.
Early‐onset gestational diabetes mellitus (diagnosed before 20 weeks) identifies a clinically higher‐risk phenotype than late‐onset GDM (24–28 weeks), with greater insulin requirement and higher adjusted risks of preeclampsia, cesarean delivery, preterm birth, and adverse neonatal outcomes.
Baolai Li, Wenjun Ji, Rui Zhao, Jinchun Zhang   +3 more
wiley   +1 more source

Association between polycystic ovarian syndrome and psychiatric morbidity in a rural setting: A cross-sectional study. [PDF]

Ind Psychiatry J
Koyilada G, Salaam MA, Ramyakrishna K.
europepmc   +1 more source